Measles cases exceed 900 in the US as outbreaks spread
Measles cases exceed 900 in the US as outbreaks spread
- Over 900 measles cases have been confirmed in the U.S., with new reports indicating 177 cases last week.
- The majority of infections are among unvaccinated individuals, with health officials linking many cases to close contacts.
- Continued outbreaks raise concerns about the United States' elimination status for measles and the importance of vaccinations.
Story
In the United States, recent data reported over 900 confirmed cases of measles, indicating a concerning rise in infections across 24 states. The Centers for Disease Control and Prevention (CDC) reported a significant increase with at least 177 new cases occurring within just the last week. Most of these infections have been observed among unvaccinated individuals, and approximately 94% of cases stem from people who have not received the measles vaccination or whose vaccination status remains unclear. The states particularly affected include Arizona, California, Colorado, Florida, and New York, among others. In South Carolina, a persistent outbreak that began last year has contributed largely to the climbing national count, with Spartanburg County being a notable epicenter of infections. Health officials highlight that many of the newly reported cases are connected to previously identified patients, showcasing how the outbreak is being sustained through close contact transmission. Additionally, a separate outbreak has occurred at Ave Maria University in southern Florida, underscoring how local outbreaks can emerge rapidly and spread within communities. While the outbreak in Texas started a year ago, indicating prolonged circulation of the virus, health experts express concerns that cases linked to this outbreak may result in the loss of the U.S.'s measles elimination status if widespread transmission continues unchecked. The CDC emphasizes the importance of vaccinations, recommending that individuals receive two doses of the measles, mumps, and rubella (MMR) vaccine: the first between 12 to 15 months of age and the second from ages 4 to 6. Vaccination effectiveness statistics reveal that one dose provides 93% protection, whereas two doses increase this to 97%. Despite these high levels of efficacy, the current ongoing outbreaks demonstrate the challenges faced in achieving adequate community immunity, particularly in areas experiencing vaccine hesitancy.